The biology of ergothioneine, an antioxidant nutraceutical
Ergothioneine (ERG) is an unusual thio-histidine betaine amino acid that has potent
antioxidant activities. It is synthesised by a variety of microbes, especially fungi (including in …
antioxidant activities. It is synthesised by a variety of microbes, especially fungi (including in …
Natural bioactive compounds from fungi as potential candidates for protease inhibitors and immunomodulators to apply for coronaviruses
The inhibition of viral protease is an important target in antiviral drug discovery and
development. To date, protease inhibitor drugs, especially HIV-1 protease inhibitors, have …
development. To date, protease inhibitor drugs, especially HIV-1 protease inhibitors, have …
Antiviral, Cytotoxic, and Antioxidant Activities of Three Edible Agaricomycetes Mushrooms: Pleurotus columbinus, Pleurotus sajor-caju, and Agaricus bisporus
In this study, we investigated aqueous extracts of three edible mushrooms: Agaricus
bisporus (white button mushroom), Pleurotus columbinus (oyster mushroom), and Pleurotus …
bisporus (white button mushroom), Pleurotus columbinus (oyster mushroom), and Pleurotus …
Could ergothioneine aid in the treatment of coronavirus patients?
IK Cheah, B Halliwell - Antioxidants, 2020 - mdpi.com
Infection with SARS-CoV-2 causes the coronavirus infectious disease 2019 (COVID-19), a
pandemic that has, at present, infected more than 11 million people globally. Some COVID …
pandemic that has, at present, infected more than 11 million people globally. Some COVID …
Proteome Analysis and In Vitro Antiviral, Anticancer and Antioxidant Capacities of the Aqueous Extracts of Lentinula edodes and Pleurotus ostreatus Edible …
In this study, we examined aqueous extracts of the edible mushrooms Pleurotus ostreatus
(oyster mushroom) and Lentinula edodes (shiitake mushroom). Proteome analysis was …
(oyster mushroom) and Lentinula edodes (shiitake mushroom). Proteome analysis was …
Medicinal mushrooms: a comprehensive study on their antiviral potential
M Sevindik, C Bal, EC Eraslan, I Uysal… - Prospects in …, 2023 - prospects.wum.edu.pl
Microbial diseases have become quite common in recent years. The interest in new
antimicrobial drugs is increasing due to the possible side effects of synthetic drugs and the …
antimicrobial drugs is increasing due to the possible side effects of synthetic drugs and the …
Effects of Agaricus bisporus Mushroom Extract on Honey Bees Infected with Nosema ceranae
Simple Summary Nosema ceranae affects honey bee (Apis mellifera L.) causing nosemosis
disease that often induces serious problems in apiculture. Antibiotic fumagillin is the only …
disease that often induces serious problems in apiculture. Antibiotic fumagillin is the only …
Edible fungus-derived bioactive components as innovative and sustainable options in health promotion
X Wang, Y Han, S Li, H Li, M Li, Z Gao - Food Bioscience, 2024 - Elsevier
Edible fungi are recognized as the novel superfood due to low fat, high protein and multiple
bioactivities. Despite its widespread popularity worldwide, the action mechanisms …
bioactivities. Despite its widespread popularity worldwide, the action mechanisms …
Rationalization of mushroom-based preventive and therapeutic approaches to COVID-19
MA Rahman, MS Rahman, NMB Bashir… - … Journal of Medicinal …, 2021 - dl.begellhouse.com
Since December 2019, a de novo pattern of pneumonia, later named coronavirus disease
2019 (COVID-19), has caused grave upset throughout the global population. COVID-19 is …
2019 (COVID-19), has caused grave upset throughout the global population. COVID-19 is …
[HTML][HTML] Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses
M del Rosario García-Lozano, F Dragoni, P Gallego… - Bioorganic …, 2023 - Elsevier
Abstract Since 2011 Direct Acting antivirals (DAAs) drugs targeting different non-structural
(NS) viral proteins (NS3, NS5A or NS5B inhibitors) have been approved for clinical use in …
(NS) viral proteins (NS3, NS5A or NS5B inhibitors) have been approved for clinical use in …